Mechanisms controlling higher-order chromatin structure or chromatin compaction and linking this to gene regulation are poorly understood. Previously, we had shown that the PRC1 Polycomb repressive complex is required to maintain a compact chromatin state at Polycomb target loci in embryonic stem cells (ESCs) of the mouse and that this activity, together with the ability to repress target gene expression, is surprisingly independent of the histone ubiquitination activity of the Ring1B component of PRC1.
In vitro, Polycomb proteins and complexes can compact nucleosome arrays (Francis et al. 2004; Margueron et al. 2008) . In vivo, both principal Polycomb repressive complexes (PRC1 and PRC2) have been implicated in maintaining a compact chromatin structure at an imprinted gene cluster in trophoblast stem cells and trophectoderm (Terranova et al. 2008 ), and we have recently shown that the PRC1 component Ring1B, and likely PRC1 itself, is required to keep the murine Hox gene loci-well-known Polycomb targets-in a compact state in ESCs (Eskeland et al. 2010) . In that system, we suggest that the primary function of the PRC2 complex (Ezh2/Suz12/Eed) is to trimethylate histone H3 at lysine 27 (H3K27me3) via the histone methyltransferase (HMTase) activity of Ezh2. This provides a binding platform for PRC1 (Boyer et al. 2006; Ku et al. 2008) via the affinity of the chromodomain of the Polycomb homologs for H3K27me3 (Kuzmichev et al. 2002; Wang et al. 2004b; Bernstein et al. 2006) . Whereas methylation of H3K79 and H4K20 can affect the structure of the nucleosome and high-order chromatin structure (Lu et al. 2008) , there is no evidence that H3K27me3 per se can alter nucleosome interactions to change higher-order structure (Simon and Kingston 2009) . Even a canonical PRC2 complex has little effect on nucleosome arrays in vitro, although a modified PRC2 complex that contains Ezh1 instead of Ezh2 does compact nucleosome arrays, despite the absence of robust HMTase activity by Ezh1 (Margueron et al. 2008) .
CHROMATIN COMPACTION AT HOX LOCI IN ESCS REQUIRES PRC1
In ESCs, PRC2 is bound at, and mediates, H2K27 trimethylation at developmentally regulated genes, including Hox loci (Azuara et al. 2006; Bernstein et al. 2006; Boyer et al. 2006; Jorgensen et al. 2006; Lee et al. 2006; Stock et al. 2007; Endoh et al. 2008) . H3K27me3 is lost from Hox loci during ESC differentiation, and concomitant with this, we have used fluorescence in situ hybridization (FISH) to show that the chromatin at Hox loci decompacts (Eskeland et al. 2010) , recapitulating what is seen in the embryo proper, at sites of Hox gene activation (Chambeyron et al. 2005; Morey et al. 2007 ). We ascribed this chromatin decompaction to loss of the PRC1 complex, rather than PRC2 activity per se, because compaction is lost in ESCs mutant for the PCR1 component Ring1B, even though H3K27me3 still extensively decorates Hox loci in the mutant cells (Eskeland et al. 2010) .
But how does the PRC1 complex compact chromatin at its target loci? Like PRC2, PRC1-like complexes also have histone-modifying activity. Ring1A, and the Ring1B component that is in mammalian PRC1 as well as several other complexes, can ubiquitinate H2AK119 through their E3 ligase activities (de Napoles et al. 2004; Wang et al. 2004a) . Monoubiquitination of histone H2A by the PRC1 complex depends on the interaction of Ring1B with another Ring-domain-containing component of PRC1 (Fig.  1A) , either Bmi1 (Buchwald et al. 2006 ) or Mel18 (Elderkin et al. 2007 ).
In the absence of Ring1B (Ring1B -/-), other PRC1 components are also lost, presumably by protein degradation, and levels of H2AK119 ubiquitination decrease (Leeb and Wutz 2007; Eskeland et al. 2010) . H2A ubiquitination (Fig. 1C) , the stability of the PRC1 complex (Fig. 1D) , and also chromatin compaction (Fig. 1E ) are all restored when wild-type Ring1B is reintroduced into Ring1B -/-ESCs. This confirms that chromatin decompaction is likely a direct result of loss of PRC1. 
PRC1-MEDIATED CHROMATIN COMPACTION AT HOX LOCI DOES NOT REQUIRE HISTONE UBIQUITINATION BY RING1B
Ubiquitin ligase activity resides in the amino-terminal Ring domain of Ring1B, not Bmi1 (Buchwald et al. 2006; Li et al. 2006) . Moreover, the E3 ligase activity of Ring1B /Bmi1 or Ring1B/Mel18 critically depends on interaction with an E2 enzyme to catalyze ubiquitin transfer from the E2 to the target (Buchwald et al. 2006; Elderkin et al. 2007) .
On the basis of other known E2-E3 structures, modeling of the Ring1B/Bmi1 heterodimer with E2-UbcH5c predicts that isoleucine 53 (Ile 53) of Ring1B should be an important contact residue with the E2. Indeed, mutation of this residue (I53A) did abrogate H2A ubiquitination in vitro without affecting Ring1B/Bmi1 or Ring1B/Mel18 interaction (Fig.  1B) (Buchwald et al. 2006; Elderkin et al. 2007) .
Consistent with these in vitro data, we found that rescue of Ring1B-null ESCs with an I53A mutant Ring1B did not restore global H2A ubiquitination (Fig. 1C ) but did reestablish an apparently intact PRC1-like complex (Fig. 1D) . Surprisingly, this mutant form of Ring1B was also able both to rerepress Hox gene expression (Eskeland et al. 2010 ) and recompact Hox chromatin structure (Fig. 1F) . Hence, we concluded that the H2A ubiquitination activity of Ring1B is not required for chromatin compaction and gene silencing. Rather, we suggest that it is chromatin compaction itself that may be directly responsible for gene silencing.
HISTONE ACETYLATION AND CHROMATIN COMPACTION
So, do the findings described above eliminate histone modification from a direct role in Polycomb-mediated chromatin compaction? It has been suggested that among histone modifications, acetylation in particular can directly affect secondary chromatin structures. This could be mediated by, for example, acetylation altering nucleosome-DNA or nucleosome-nucleosome interactions and by neutralizing charge in the histone amino-terminal tails (Tse et al. 1998; Wolffe and Hayes 1999; Carruthers and Hansen 2000; Wang et al. 2001; Shogren-Knaak et al. 2006; Henikoff 2008; Robinson et al. 2008) . Moreover, in mammalian cells, the inhibition of histone deacetylases (HDACs) and the consequently increased steady-state levels of histone acetylation both decrease chromatin compaction (Toth et al. 2004; Lleres et al. 2009 ) and increase chromatin accessibility (Gorisch et al. 2005) .
HISTONE DEACETYLATION LEADS TO CHROMATIN DECOMPACTION AT POLYCOMB TARGET LOCI
Polycomb complexes have also been associated with histone deacetylation. In mammalian cells, the PRC2 component EED interacts with the HDACs 1 and 2 (van der Vlaag and Otte 1999), and HDAC2 copurifies in a PRC2 complex (Pasini et al. 2010 ). In addition, HDAC1 copurifies with both PRC2 (Kuzmichev et al. 2002) and PRC1 (Chang et al. 2001) . In Drosophila, the HDAC RPD3 can be found in a 1MDa PRC2-like complex, is present at a Polycomb response element (PRE), and is required for Polycomb silencing (Tie et al. 2003) . Likewise, the dMi-2 component of an HDAC complex also interacts genetically with Polycomb mutations (Kehle et al. 1998) . HDAC complexes have been implicated in Polycomb silencing in mammalian cells: The NuRD complex facilitates Polycomb binding and H3K27 methylation in acute promyelocytic leukemia (Morey et al. 2008) . Finally, the Class III (NAD + -dependent) HDAC SirT1 has been found in a PRC2-like complex in undifferentiated ESCs (Kuzmichev et al. 2005) . A causal role for histone deacetylation in Polycomb-mediated silencing is evidenced by the up-regulation of α-globin expression in human cells after treatment with HDAC inhibitors (Garrick et al. 2008) .
Given the association of HDACs with Polycomb complexes, the suggested role of histone acetylation in opening chromatin structure, and the fact that the HDAC inhibitor trichostatin A (TSA) can induce basal (~fivefold) expression of a Polycomb-silenced gene in human ESCs (Garrick et al. 2008) , we sought to determine whether there might be a role for histone deacetylation in PRCmediated chromatin compaction.
In a previous study, we had not seen effects of TSA on Hox chromatin compaction in ESCs (Chambeyron and Bick- (lanes 1-3) , Ring1B
-/-(lanes 4-6), EGFP WT (lanes 7-9), or Ring1BI53A (lanes 10-12) nuclear extracts. Ten percent of total protein extracts were loaded as inputs. Western blots were probed with antibodies against Ring1B, Mel18 (Santa Cruz Biotechnology), and RYBP (AB3637; Chemicon/Millipore). (E) Ring1B-null cells rescued with WT Ring1B recompact chromatin structure at Hoxb loci. FISH with probe pairs at Hoxb and a control locus on chromosome 11 in methanol-acetic acid-fixed nuclei of dsRed_Ring1B (null for Ring1B expression) and EGFP_Ring1B ESCs counterstained with DAPI (blue). Bar, 5 µm. Above the images, the diagrams show the probe positions in the UCSC Mouse Genome Browser (Feb. 2006 assembly, mm8 build 36) . Genome position is in base pairs. Below images, box plots show distribution of interprobe distances squared (d 2 ) normalized for nuclear radius squared (r 2 ). (Shaded boxed areas) Median and interquartile range of data; (asterisks) outliers. n = 2 biological replicates, each of 100 loci. Statistical significance of differences was examined by Mann-Whitney U tests. (F) As in E, but for the I53A mutant Ring1B. (A, B, Adapted, with permission, from Buchwald et al. 2006.) more 2004), but given the current understanding of the effects of TSA on cell cycle and differentiation (Taddei et al. 2005; Karantzali et al. 2008) , the concentrations of TSA used in that study (160 nM TSA for 24 h) were likely too high.
Undifferentiated ESCs, grown in the presence of LIF, were seeded at 1 x 10 5 cells/mL, and after 3 d TSA (Sigma), dissolved in dimethyl sulfoxide (DMSO), was added to a final concentration of 50 nM and incubated for 4 h at 37°C. Control cells were incubated in DMSO for the same time period. Western blotting ( Fig. 2A) indicated that this treatment was sufficient to increase bulk levels of acetylated H3K9 in the ESCs without a detectable decrease in levels of Oct4. FACs sorting indicated that, indeed, >90% of TSA-treated cells remain positive for Oct4 (Fig. 2B ) and, together with alkaline phosphatase staining of the treated ESC colonies (Fig. 2C) , suggested that this short TSA treatment had not induced differentiation (Karantzali et al. 2008 ).
Immunoprecipitation of uncross-linked, micrococcal nuclease-digested chromatin (nChIP) in presence of 5 mM sodium butyrate, using a modification of previously described methods (Hebbes et al. 1988; O'Neill and Turner 2003; Eskeland et al. 2010 ), followed by real-time PCR analysis, showed that the TSA treatment resulted in significantly increased levels of H3k9Ac at Hox loci, and to a lesser extent at another Polycomb target locus in ESCs, Olig2 (Fig. 3A) . TSA actually induces a decrease in H3K9Ac at loci that are already active and hyperacetylated in undifferentiated ESCs (β-actin and Pou5f1/Oct4), correlating with observations that H3ac gradually decreases at the Nanog promoter during a TSA time course in ESCs (Karantzali et al. 2008 ). These data suggest that the overall balance, as well as the absolute levels, of histone acetylation in ESCs is altered by TSA treatment.
One trivial explanation for any effect of TSA on Polycomb target loci might have been that TSA induces acetylation of H3K27, replacing H3K27me3 and thus antagonizing PRC1 binding (Banerjee et al. 2009; Pasini et al. 2010) . However, nChIP revealed that H3K27me3 was still present at the promoters of Hox genes and Olig2 in TSA-treated ESCs (Fig. 3B) , as has previously been reported for other Polycomb targets in TSA-treated human (Garrick et al. 2008 ) and mouse ESCs (Karantzali et al. 2008) .
FISH analysis with fosmid probe pairs that span the Hoxb and Hoxd loci and a control locus (Hbq1-Il9r) was used to assess the state of chromatin compaction at these loci in untreated and TSA-treated ESCs. We have used this method extensively to assess chromatin decompaction at Hox loci during differentiation and development (Chambeyron et al. 2005; Morey et al. 2007 ). Interprobe distances (d 2 ) were normalized to nuclear radius squared (r 2 ). To estimate the nuclear radius, nuclear area was measured from the total DAPI-stained area and converted to the radius of a circle of the same area (Area = πr 2 ). Thus, final interprobe separation is expressed as d 2 /r 2 . The statistical significance of differences in normalized mean-squared interprobe distances was assessed using the nonparametric Mann-Whitney U test to examine the null hypothesis that two sets of data show the same distribution.
This FISH analysis did reveal a significant decompaction at Hox loci in TSA-treated ESCs, but not at a control non-Polycomb target locus (Fig. 4) . However, this decompaction was not as great (twofold less) as that seen in cells that lack PRC2 or PRC1 (Fig. 5A) Cold Figure 1E . n = 2 x biological replicates, n = 100 loci each.
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Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by symposium.cshlp.org Downloaded from al. 2010). Although at a gross cytological level TSA is known to be capable of inducing visible chromatin decondensation (Toth et al. 2004; Lleres et al. 2009 ), these studies were not able to ascertain whether this decompaction was global or specific to certain loci. Here we have shown that the effects of TSA on chromatin compaction are not global and that loci subject to Polycomb-mediated repression seem to be one class of loci susceptible to TSA-mediated chromatin decompaction.
HISTONE DEACETYLATION IS IN POLYCOMB-MEDIATED CHROMATIN COMPACTION PATHWAY
TSA treatment, and the consequent elevated levels of histone acetylation, may act within the Polycomb pathway itself or through a parallel one. In the latter case, TSA treatment of PRC mutant cells might lead to even further levels of chromatin decompaction above and beyond those seen in the mutant cells alone. In the former case, TSA treatment of Polycomb mutant cells might not give any additive effect.
To determine whether chromatin decompaction mediated by TSA treatment or by loss of Ring1B is synergistic or redundant, we analyzed chromatin compaction at Hox loci in feeder-dependent wild-type (WT) (Ring1B +/+ ) and Ring1B-null (Ring1B -/-) cells (Leeb and Wutz 2007; Eskeland et al. 2010) , and these same cells treated with 50 nM TSA for 3 h with an additional hour of fibroblast reattachment in the presence of TSA to separate the ESCs from the feeders (i.e., total of 4 h of TSA treatment).
As seen with OS25 ESCs (Fig. 4) , TSA treatment decompacts chromatin at Hoxd in the parental WT (Ring1B +/+ ) ESCs (Fig. 5A ), but it had no further effect on the already decompacted Hox loci in Ring1B -/-cells (Fig.  5B) . This is consistent with the effects of PRC1 and histone deacetylation being in the same pathway of chromatin compaction.
MECHANISMS OF TRANSCRIPTIONAL REPRESSION BY HISTONE DEACETYLATION AND POLYCOMB
The presence of transcription initiation factors and RNAPII at the promoters of inactive Hox genes and at a Polycomb repressed reporter in Drosophila (Breiling et al. 2001; Dellino et al. 2004) suggests that PRC1 inhibits steps downstream from RNAPII binding itself, such as promoter opening or transcriptional elongation (Zhou et al. 2008 ). Indeed, a form of RNA polymerase II, detected by antibodies that recognize the serine 5 phosphorylated form (RNAPII Ser5P), is found at Hox genes in ESCs, and Ring1B is necessary to prevent this RNAPII from proceeding to productive transcriptional elongation (Stock et al. 2007 ). Therefore, the challenge is to understand how PRC1-mediated physical compaction and histone hypoacetylation might act to block transcriptional elongation or, alternatively, to favor early termination (Buratowski 2009 ).
In vitro, one PRC1-like complex can compact three nucleosomes (Francis et al. 2004 ) and thus could act as a bridge chromatin fibers. Alternatively, PRC1 binding to nucleosomes might act to block nucleosome mobility, and, indeed, PRCs do block chromatin remodeling in vitro (Francis et al. 2001) . Exciting new evidence provides support for a role of Polycomb in regulating nucleosome stability in vivo (Deal et al. 2010 ) with nucleosomes at Polycomb-silenced regions in Drosophila tissue culture cells having a longer lifetime at these loci (1.5 h) than do nucleosomes at active genes. The hypoacetylation of histone tails, particularly those on the (H3-H4) 2 tetramer, might also similarly act to further increase nucleosome stability (Henikoff 2008) . We suggest that together, PRC1 binding and histone hypoacetylation create a chromatin template in which nucleosomes are rather stably bound and thus disfavors productive elongation of mRNAs by RNAPII.
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